fluorodeoxyglucose f18 has been researched along with sodium fluoride in 102 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (2.94) | 29.6817 |
| 2010's | 75 (73.53) | 24.3611 |
| 2020's | 24 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Bergh, S; Boerner, AR; Brunkhorst, T; Gratz, FW; Knapp, WH; Otto, D | 1 |
| Fujii, R; Ido, T; Imahori, Y; Itani, K; Kanatsuna, T; Matsuura, S; Mineura, K; Nakamura, M; Nakanishi, H; Nakazawa, N; Uji, Y; Wakita, K | 1 |
| Boin, C; Bousquet, G; Cuvier, C; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Misset, JL; Moretti, JL; Teyton, P | 1 |
| Cheng, Z; Gambhir, SS; Han, P; Liu, H; Miao, Z; Ren, G; Tang, X; Zhang, X | 1 |
| Drubach, LA; Grant, FD; Johnston, PR; Kleinman, PK; Newton, AW; Perez-Rossello, JM | 1 |
| Freesmeyer, M; Hellwig, D; Krause, BJ; Schirrmeister, H | 1 |
| Dick, DW; Gambhir, SS; Iagaru, A; Mittra, E | 1 |
| Apostolova, I; Derlin, T; Habermann, CR; Klutmann, S; Mester, J; Papp, L; Tóth, Z; Wisotzki, C | 1 |
| Chengapa, A; Dick, DW; Gambhir, SS; Iagaru, A; Lin, FI; Mittra, ES; Nallapareddy, K; Rao, JE | 1 |
| Braziewicz, J; Hołody, Ł; Królicki, L; Tarnawska-Pierścińska, M | 1 |
| Aoki, M; Hatazawa, J; Imaizumi, M; Kanai, Y; Kato, H; Shimosegawa, E; Tatsumi, M; Watabe, T; Yamamoto, S | 1 |
| Boon, NA; Chow, MW; Dweck, MR; Fletcher, AM; Jones, C; Joshi, NV; McKillop, G; Newby, DE; Richardson, H; Rudd, JH; van Beek, EJ; White, A; Williams, MC | 1 |
| George, RT | 1 |
| Conti, PS; Desai, B; Dorff, TB; Groshen, SG; Gross, ME; Jadvar, H; Ji, L; Pinski, JK; Quinn, DI | 1 |
| Alavi, A; Mohler, ER; Wilensky, RL | 1 |
| Baird, A; Boon, NA; Dweck, MR; Joshi, NV; Khaw, HJ; Luo, EL; Makiello, P; Mirsadraee, S; Newby, DE; Rudd, JH; Sng, GK; van Beek, EJ; Williams, MC | 1 |
| Dick, DW; Gambhir, SS; Herfkens, R; Iagaru, A; Mittra, E; Young, P | 1 |
| Cascini, GL; Cuccurullo, V; Mansi, L; Rotondo, A; Tamburrini, O | 1 |
| Chen, W; Dilsizian, V | 1 |
| Avery, R; Kuo, PH | 1 |
| Bahri, MA; Blomme, A; Bretin, F; Castronovo, V; Lemaire, C; Libert, LC; Luxen, A; Plenevaux, AR; Seret, AE; Turtoi, A; Warnock, G | 1 |
| Chen, Y; Cui, Y; Guan, Z; Jiang, C; Lei, R; Liu, H; Wang, A; Wang, Z; Wu, X; Xia, T; Yang, L; Yu, L; Zeng, Q; Zhang, C; Zhang, S; Zhang, X | 1 |
| Bal, CS; Karunanithi, S; Sahoo, MK | 1 |
| Ouvrier, MJ; Thariat, J; Vignot, S | 1 |
| Liu, F; Pastakia, B; Xu, F | 1 |
| Behan, MW; Calvert, PA; Craighead, FH; Cruden, NL; Dweck, MR; Flapan, AD; Fletcher, AM; Fox, KA; Joshi, NV; Mills, NL; Newby, DE; Rudd, JH; Salter, D; Shah, AS; Uren, NG; van Beek, EJ; Vesey, AT; Wallace, W; Williams, MC; Yeoh, SE | 1 |
| Anez-Bustillos, L; Araiza Arroyo, FJ; Aran, S; Entezari, V; Luu, AN; Nazarian, A; Rosso, C; Snyder, BD | 1 |
| Boon, NA; Chin, CW; Cowie, WJ; Dweck, MR; Fletcher, A; Jenkins, WS; Malley, TS; Newby, DE; Pessotto, R; Pringle, MA; Richardson, H; Rudd, JH; Tsampasian, V; van Beek, EJ; Vesey, AT; Wallace, WA | 1 |
| Cheng, C; Dimitrakopoulou-Strauss, A; Goldschmidt, H; Haberkorn, U; Hose, D; Kopka, K; Pan, L; Sachpekidis, C | 1 |
| Coleman, RE; Duan, F; Hanna, L; Hillner, BE; Shields, AF; Siegel, BA | 1 |
| Dweck, MR; Newby, DE; Toor, IS | 1 |
| Jeraj, R; Liu, G; Perlman, S; Simoncic, U; Staab, MJ; Straus, JE | 1 |
| Gambhir, SS; Iagaru, A; Lutz, AM; Mittra, ES; Mosci, C; Sampath, SC; Willmann, JK | 1 |
| Duan, F; Hanna, L; Hillner, BE; Quinn, B; Shields, AF; Siegel, BA | 1 |
| Chan, HP; Hu, C; Huang, TC; Peng, NJ; Yu, CC | 1 |
| Barkhodari, A; Gambhir, SS; Habte, F; Iagaru, A; Jackson, T; Jamali, M; Minamimoto, R; Mittra, E; Mosci, C | 1 |
| Biswal, S; Gambhir, SS; Ganjoo, K; Iagaru, A; Jackson, T; Mittra, E; Mosci, C; von Eyben, R | 1 |
| Buscombe, JR | 1 |
| Banzo, I; Carril, JM; Ibáñez-Bravo, S; Jiménez-Alonso, M; Jiménez-Bonilla, J; López-Defilló, J; Martínez-Amador, N; Martínez-Rodríguez, I; Quirce, R; Revilla, MA | 1 |
| Altrinetti, V; Bongioanni, F; DeCensi, A; Gennari, A; Gonella, R; Iacozzi, M; Massollo, M; Morbelli, S; Paparo, F; Piccardo, A; Puntoni, M; Sambuceti, G | 1 |
| Comert, M; Ömür, Ö; Oral, A; Saydam, G; Yazici, B | 1 |
| Choi, KJ; Kosmas, CE; Lerakis, S; Madanieh, R; Tsomidou, C; Vittorio, TJ | 1 |
| Boon, NA; Brown, OS; Cartlidge, TR; Chin, CW; Dweck, MR; Fletcher, A; Jenkins, WS; McKillop, G; Mitchell, AJ; Newby, DE; Pawade, TA; Pessotto, R; Pringle, MA; Rudd, JH; Shah, AS; Van Beek, EJ; Vesey, AT; White, AC | 1 |
| Jeraj, R; Liu, G; Perlman, S; Simoncic, U | 1 |
| Barkhodari, A; Gambhir, SS; Iagaru, A; Jackson, T; Jamali, M; Loening, A; Minamimoto, R; Mosci, C; Obara, P; Taviani, V; Vasanawala, S | 1 |
| Kim, BS; Kim, Y; Lee, HY; Yoon, HJ | 1 |
| Buchpiguel, CA; Carvalho, G; Duarte, PS; Garcez, AT; Marin, JF; Sapienza, MT | 1 |
| Berent, R; Brammen, L; Sinzinger, H; Steiner, S | 1 |
| Chen, Z; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X; Zong, Z | 1 |
| Gorgoni, G; Gori, S; Inno, A; Lunardi, G; Pasetto, S; Salgarello, M; Severi, F | 1 |
| Bokhari, S; Chen, J; DeLuca, A; Morgenstern, R; Weinberg, RL | 1 |
| Ashamalla, M; Grimm, R; Hegener, P; Koutroumpakis, E; McCarthy, L; Mehdi, S | 1 |
| Cai, L; Chen, L; Chen, Y; Huang, H; Huang, Z | 1 |
| Alexanderson-Rosas, E; Estrada, E; Garcia-Pérez, O; Juarez-Orozco, LE; Martinez-Aguilar, MM; Monroy-Gonzalez, AG; Soldevilla, I; Soto-Lopez, ME | 1 |
| Chen, Y; Huang, Z; Shao, F; Wu, J; Zhou, F | 1 |
| Cai, L; Chen, Y; Shao, F; Wang, X; Zou, Y | 1 |
| Bagci, U; Blau, J; Collins, MT; Millo, C; Papadakis, GZ | 1 |
| Pipitone, N; Salvarani, C; Versari, A | 1 |
| Chen, Y; Huang, Z; Liu, L; Zhu, Y | 1 |
| Abgral, R; Contreras, J; Dweck, MR; Fayad, ZA; Fuster, V; Gidwani, U; Karakatsanis, NA; Kovacic, JC; Narula, JP; Robson, PM; Trivieri, MG | 1 |
| Narayan, N; Owen, DR; Taylor, PC | 1 |
| Kohli, PS; Mittal, BR; Roop, MJ; Singh, B; Singh, G; Singh, H; Watts, A | 1 |
| Fayad, ZA; Osborne, MT; Tawakol, A | 1 |
| Costa, G; Lapa, P; Lima, JP; Marques, M; Saraiva, T; Silva, R | 1 |
| Goldberg, H; Hamilton, RJ | 1 |
| Alavi, A; Blomberg, BA; de Jong, PA; Hess, S; Høilund-Carlsen, PF; Lam, MGEH; Mali, WPTM; Olsen, MH; Thomassen, A | 1 |
| Chen, Y; Huang, Z; Qi, C; Xia, Y; Zhang, S | 1 |
| Ahlquist, P; Ellingsen, T; Gram, SB; Hess, S; Høilund-Carlsen, PF | 1 |
| Lacoeuille, F; Leftheriotis, G; Martin, L; Mention, PJ; Omarjee, L | 1 |
| Alavi, A; Alloosh, M; Houshmand, S; Høilund-Carlsen, PF; McKenney-Drake, ML; Moe, S; Moghbel, MC; Paydary, K; Salavati, A; Sturek, JM; Sturek, M; Territo, PR; Weaver, C; Werner, TJ | 1 |
| Fraum, TJ; Hope, TA; Ippolito, JE; Kim, EH; Ludwig, DR; Schroeder, P | 1 |
| Al-Zaghal, A; Alavi, A; Constantinescu, CM; Høilund-Carlsen, PF; Moghbel, M; Werner, TJ | 1 |
| Kim, JM; Kwon, OS; Lee, ES; Park, KY; Seok, JW | 1 |
| Dweck, MR; Fletcher, AJ; Forsythe, R; Newby, DE; Syed, MBJ | 1 |
| Alavi, A; Gerke, O; Høilund-Carlsen, PF; Moghbel, MC | 1 |
| Kairemo, K; Subbiah, V; Wang, WL | 1 |
| Alavi, A; Ayubcha, C; Kothekar, E; Raynor, WY; Seraj, SM; Werner, T; Zadeh, MZ | 1 |
| Albaghdadi, MS; Berrett, TB; Buscombe, JR; Chowdhury, MM; Coughlin, PA; Dweck, MR; Evans, NR; Hayes, PD; Joshi, FR; Le, EPV; Newby, DE; Rudd, JHF; Sadat, U; Tarkin, JM; Warburton, EA | 1 |
| Fujimoto, K; Hatakeyama, T; Kawanishi, M; Mitamura, K; Nishiyama, Y; Norikane, T; Okada, M; Takami, Y; Yamamoto, Y | 1 |
| Akerele, MI; Aykroyd, RG; Dweck, MR; Forsythe, RO; Karakatsanis, NA; Newby, DE; Sourbron, S; Syed, M; Tsoumpas, C | 1 |
| Lassen, ML; Slomka, PJ | 1 |
| Duarte, PS; Sapienza, MT | 1 |
| Appelman-Dijkstra, NM; de Geus-Oei, LF; van der Bruggen, W; Vriens, D | 1 |
| Beghetto, B; Besutti, G; Ciusa, G; Esposito, F; Guaraldi, G; Ligabue, G; Malagoli, A; Milic, J; Mussini, C; Nardini, G; Prandini, N; Raggi, P; Roncaglia, E; Scaglioni, R | 1 |
| Al-Zaghal, A; Alavi, A; Arani, LS; Baker, JF; Gerke, O; Hunt, SJ; Høilund-Carlsen, PF; Raynor, WY; Revheim, ME; Rojulpote, C; Seraj, SM; Werner, TJ; Zadeh, MZ | 1 |
| Kim, SH; Kim, SJ; Kim, YS | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Benz, DC; Buechel, RR; Dorbala, S | 1 |
| Kitagawa, T; Nakano, Y | 1 |
| Glasgow, KW | 1 |
| Dweck, MR; Kwiecinski, J | 1 |
| Kwiecinski, J | 1 |
| Edenbrandt, L; Enqvist, O; Gerke, O; Høilund-Carlsen, PF; Larsson, M; Nøddeskou-Fink, AH; Piri, R; Stochkendahl, MJ | 1 |
| Alavi, A; Høilund-Carlsen, PF; Revheim, ME; Werner, TJ | 1 |
| Alavi, A; Høilund-Carlsen, PF; Khurana, N; Park, PSU; Werner, TJ | 1 |
| Al-Momani, E; Ali, H; Awad, E; Lamb, J | 1 |
| Alavi, A; Høilund-Carlsen, PF; McDonald, E; Park, PSU; Raynor, WY; Singh, SB; Werner, TJ | 1 |
| Graham, RN; Panagiotidis, E | 1 |
| Alavi, A; Gerke, O; Høilund-Carlsen, PF; Madsen, PL; Piri, R; Revheim, ME; Sturek, M; Werner, TJ | 1 |
| Abikhzer, G; Bénard, F; Black, P; Burrell, S; Cossette, M; Eigl, BJ; Harsini, S; Krauze, A; Mar, C; Martin, M; Metser, U; Nichol, A; Romsa, J; Saad, F; Soucy, JP; Tardif, JC; Turcotte, E; Wilson, D; Zukotynski, K | 1 |
| Joy, AK; Kottuparamban, D; Muhammed, AK; Nair, KNS; Nanabala, R; Pillai, MRA; Pokkat, J; Singh, MK | 1 |
| Alavi, A; Høilund-Carlsen, PF; Park, MM; Park, PSU; Werner, TJ | 1 |
21 review(s) available for fluorodeoxyglucose f18 and sodium fluoride
| Article | Year |
|---|---|
[PET/CT in breast cancer: an update].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Treatment Outcome | 2009 |
Bone metastases diagnosis possibilities in studies with the use of 18F-NaF and 18F-FDG.
Topics: Bone Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2011 |
Bone metastases radiopharmaceuticals: an overview.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Sodium Fluoride; Somatostatin; Technetium; Thymidine; Tomography, Emission-Computed, Single-Photon | 2013 |
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Topics: Calcinosis; Coronary Angiography; Coronary Artery Disease; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Rupture, Spontaneous; Sodium Fluoride; Tomography, X-Ray Computed | 2013 |
[State of the art in nuclear imaging for the diagnosis of bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Thyroid Neoplasms | 2013 |
Molecular imaging of the atherosclerotic plaque using positron emission tomography.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed | 2014 |
Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET).
Topics: Aortic Aneurysm; Atherosclerosis; Coronary Vessels; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Vascular Calcification; Vasculitis | 2015 |
Lipid Interventions in Aortic Valvular Disease.
Topics: Aorta; Aortic Valve; Apolipoprotein A-I; Bicuspid Aortic Valve Disease; Cardiology; Clinical Trials as Topic; Constriction, Pathologic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Regulation; Heart Defects, Congenital; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Lipids; Lipoprotein(a); Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sodium Fluoride | 2015 |
Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
Topics: Animals; Arteries; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Sodium Fluoride | 2016 |
Advances in positron emission tomography for the imaging of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Isoquinolines; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA; Rituximab; Sodium Fluoride; Synovitis | 2017 |
Novel imaging in advanced prostate cancer.
Topics: Antigens, Surface; Choline Kinase; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Grading; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Sodium Fluoride | 2017 |
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Sodium Fluoride | 2018 |
Prostate cancer PET tracers: essentials for the urologist.
Topics: Antigens, Surface; Carbon Radioisotopes; Carboxylic Acids; Cyclobutanes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Radiopharmaceuticals; Sodium Fluoride | 2018 |
The Role of PET in Evaluating Atherosclerosis: A Critical Review.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sodium Fluoride | 2018 |
Imaging aortic wall inflammation.
Topics: Aortic Aneurysm; Aortitis; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sodium Fluoride | 2019 |
Evolving Role of PET in Detecting and Characterizing Atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Contrast Media; Coronary Artery Disease; Disease Models, Animal; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Risk Factors; Sodium Fluoride; Swine; Young Adult | 2019 |
Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches.
Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2019 |
Diagnostic performance of PET for detection of cardiac amyloidosis: A systematic review and meta-analysis.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2021 |
Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging.
Topics: Atherosclerosis; Diabetes Mellitus; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
16 trial(s) available for fluorodeoxyglucose f18 and sodium fluoride
| Article | Year |
|---|---|
Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole-Body Irradiation; Young Adult | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sodium Fluoride; Tomography, X-Ray Computed | 2012 |
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.
Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation?
Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Bone Density; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Male; Osteitis; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed; Vasculitis | 2013 |
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Plaque, Atherosclerotic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Rupture, Spontaneous; Scotland; Sodium Fluoride; Tomography, X-Ray Computed | 2014 |
18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Biomarkers; Calcinosis; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Reproducibility of Results; Severity of Illness Index; Sodium Fluoride | 2014 |
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Prostatic Neoplasms; Registries; Sodium Fluoride; Treatment Outcome | 2015 |
Do we need FDG-PET/CT to assess atherosclerosis?
Topics: Adult; Aged; Aorta, Thoracic; Aortitis; Atherosclerosis; Causality; Comorbidity; Denmark; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sodium Fluoride; Survival Rate; Vascular Calcification; Young Adult | 2017 |
Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sodium Fluoride | 2017 |
Reference values for fluorine-18-fluorodeoxyglucose and fluorine-18-sodium fluoride uptake in human arteries: a prospective evaluation of 89 healthy adults.
Topics: Adult; Arteries; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Reference Values; Sodium Fluoride | 2017 |
Association between carotid
Topics: Aged; Biological Transport; Brain Ischemia; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Sodium Fluoride | 2019 |
Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients.
Topics: Aorta, Abdominal; Arthritis, Rheumatoid; Calcinosis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Fully Automated Methods for [
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sodium Fluoride | 2022 |
Intra-individual comparison of
Topics: Bone Neoplasms; Breast Neoplasms; Canada; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon | 2022 |
66 other study(ies) available for fluorodeoxyglucose f18 and sodium fluoride
| Article | Year |
|---|---|
Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique.
Topics: Adolescent; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Osteosarcoma; Radiopharmaceuticals; Sodium Fluoride; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
[Short time bacterial endotoxins test for positron emission tomography by means of positively charged filters].
Topics: Drug Contamination; Endotoxins; Fluorodeoxyglucose F18; Hydrogen-Ion Concentration; Micropore Filters; Nephelometry and Turbidimetry; Quality Control; Radiopharmaceuticals; Sodium Fluoride; Tomography, Emission-Computed | 2002 |
Molecular optical imaging with radioactive probes.
Topics: Animals; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasm Transplantation; Optics and Photonics; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Sodium Iodide; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium; Yttrium Radioisotopes | 2010 |
Skeletal trauma in child abuse: detection with 18F-NaF PET.
Topics: Child Abuse; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Sodium Fluoride | 2010 |
[Bone scanning with sodium 18F-fluoride PET and PET/CT. German guideline Version 1.0.].
Topics: Bone and Bones; Fluorides; Fluorodeoxyglucose F18; Germany; Humans; Molybdenum; Positron-Emission Tomography; Sodium Fluoride; Tomography, X-Ray Computed | 2010 |
Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Arteries; Biological Transport; Calcinosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Minerals; Plaque, Atherosclerotic; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Risk Factors; Sodium Fluoride; Tomography, X-Ray Computed; Young Adult | 2011 |
Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed | 2012 |
Simultaneous PET/MR body imaging in rats: initial experiences with an integrated PET/MRI scanner.
Topics: Animals; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Multimodal Imaging; Positron-Emission Tomography; Rats; Rats, Wistar; Sodium Fluoride; Time Factors | 2012 |
18F-sodium fluoride positron emission tomography: an in vivo window into coronary atherosclerotic plaque biology.
Topics: Coronary Artery Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sodium Fluoride | 2012 |
(18)F-fluoride imaging for atherosclerosis.
Topics: Coronary Artery Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sodium Fluoride | 2012 |
18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development.
Topics: Animals; Cell Line, Tumor; Chickens; Chorioallantoic Membrane; Disease Models, Animal; Drug Discovery; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Sodium Fluoride; Tomography, X-Ray Computed; Tumor Burden; Tyrosine | 2013 |
Low glucose utilization and neurodegenerative changes caused by sodium fluoride exposure in rat's developmental brain.
Topics: Animals; Body Weight; Brain; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glucose; Glucose Transporter Type 1; Learning Disabilities; Magnetic Resonance Imaging; Male; Maze Learning; Memory Disorders; Multimodal Imaging; Nerve Degeneration; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats; Rats, Sprague-Dawley; Sodium Fluoride; Tomography, X-Ray Computed | 2014 |
Pulmonary alveolar microlithiasis: imaging characteristics of planar and SPECT/CT bone scan versus 18F-FDG and 18F-sodium fluoride PET/CT scanning.
Topics: Calcinosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Diseases, Inborn; Humans; Lung Diseases; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rare Diseases; Sensitivity and Specificity; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
Topics: Aged, 80 and over; Bone and Bones; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed | 2014 |
Microstructural, densitometric and metabolic variations in bones from rats with normal or altered skeletal states.
Topics: Absorptiometry, Photon; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Female; Fluorodeoxyglucose F18; Ovariectomy; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Sodium Fluoride; Tomography, X-Ray Computed; Vitamin D Deficiency; X-Ray Microtomography | 2013 |
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Pelvis; Positron-Emission Tomography; Radioactive Tracers; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Cohort Studies; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Registries; Sodium Fluoride; Tomography, X-Ray Computed; United States | 2014 |
Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Clinical Trials, Phase III as Topic; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Pyrrolidines; Sodium Fluoride; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: a case report.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Injections; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sodium Fluoride; Time Factors; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2015 |
Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Carotid Arteries; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Ischemic Attack, Transient; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sodium Fluoride; Stroke; Vascular Calcification | 2016 |
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sodium Fluoride; Survival Rate; Tomography, X-Ray Computed | 2015 |
18F-FDG and 18F-NaF PET/CT Findings of a Multiple Myeloma Patient With Thyroid Cartilage Involvement.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Thyroid Cartilage; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Valvular (18)F-Fluoride and (18)F-Fluorodeoxyglucose Uptake Predict Disease Progression and Clinical Outcome in Patients With Aortic Stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Topics: Adult; Aged; Bone and Bones; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Whole Body Imaging | 2015 |
Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Fluorodeoxyglucose F18; Glucose; Multimodal Imaging; Osteonecrosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rats; Sodium Fluoride; Tomography, X-Ray Computed | 2016 |
SUV Normalized by Skeletal Volume on 18F-Fluoride PET/CT Studies.
Topics: Adult; Aged; Aged, 80 and over; Body Composition; Female; Femur; Fluorides; Fluorodeoxyglucose F18; Humans; Humerus; Middle Aged; Phosphates; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skeleton; Sodium Fluoride | 2016 |
18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Reproducibility of Results; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2016 |
18F-NaF PET/CT Imaging of Brain Metastases.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2016 |
F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride | 2017 |
Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
Topics: Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Low Back Pain; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride; Tomography, X-Ray Computed | 2016 |
Intense 99mTc-MDP and 18F-NaF Activity in Long-standing Subcutaneous Implants.
Topics: Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate | 2016 |
[
Topics: Adult; Aorta; Calcinosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Sodium Fluoride; Takayasu Arteritis; Young Adult | 2017 |
Serendipitous Detection of Hodgkin Lymphoma by 18F-NaF PET/CT.
Topics: Adolescent; Calcinosis; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2016 |
Unexpected Detection of Urinary Bladder Cancer on Dual Phase 18F-NaF PET/CT in a Patient With Back Pain.
Topics: Aged; Back Pain; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride; Urinary Bladder Neoplasms | 2016 |
18F-NaF and 18F-FDG PET/CT in Gorham-Stout Disease.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Osteolysis, Essential; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2016 |
Unsuspected Metastatic Ovarian Cancer Revealed by 18F-NaF PET/CT Performed to Evaluate Lower-Back Pain.
Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Low Back Pain; Middle Aged; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2017 |
Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.
Topics: Adult; Aged; Algorithms; Artifacts; Contrast Media; Coronary Artery Disease; Coronary Vessels; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Sodium Fluoride; Vascular Calcification | 2017 |
Molecular Imaging of Atheroma: Deciphering How and When to Use
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed | 2017 |
[Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sodium Fluoride; Young Adult | 2017 |
Elevated 18F-NaF uptake in cricoid cartilage in a patient with laryngeal carcinoma: A case report and literature review.
Topics: Carcinoma, Squamous Cell; Cricoid Cartilage; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2017 |
[
Topics: Aged; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2018 |
18F-Flurodeoxyglucose and 18F-Sodium Fluoride Positron Emission Tomography/Computed Tomography Imaging of Arterial and Cutaneous Alterations in Pseudoxanthoma Elasticum.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Pseudoxanthoma Elasticum; Radiopharmaceuticals; Sodium Fluoride | 2018 |
Comparison of [
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Sodium Fluoride; Vascular Calcification | 2019 |
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.
Topics: Adult; Bone Neoplasms; Cell Transformation, Neoplastic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Molecular Imaging; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2019 |
Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peripheral Arterial Disease; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Risk Factors; Sodium Fluoride; Time Factors; Treatment Outcome | 2020 |
Iterative reconstruction incorporating background correction improves quantification of [
Topics: Aged; Algorithms; Aortic Aneurysm, Abdominal; Bone and Bones; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sodium Fluoride | 2021 |
PET-derived bone information from 18F-sodium fluoride: A perfect match for whole-body PET/MR attenuation correction?
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sodium; Sodium Fluoride | 2020 |
Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT.
Topics: Body Weight; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2020 |
Considerations on bone volume normalization in quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT.
Topics: Bone Diseases; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2020 |
Topics: Aged; Coronary Artery Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sodium Fluoride | 2020 |
(18)F-sodium fluoride PET in multiple myeloma: Linking cancer to atherosclerosis?
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron-Emission Tomography; Sodium Fluoride | 2021 |
Innovative atherosclerosis imaging using
Topics: Atherosclerosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2022 |
Artificial intelligence-based quantification of cardiac 18F-sodium fluoride uptake.
Topics: Artificial Intelligence; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Sodium; Sodium Fluoride | 2022 |
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
PET/CT imaging of spinal inflammation and microcalcification in patients with low back pain: A pilot study on the quantification by artificial intelligence-based segmentation.
Topics: Adult; Artificial Intelligence; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Low Back Pain; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not.
Topics: Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
Coupling of Inflammation and Microcalcification in the Pathogenesis of Prostate Calculi: Detection Using 18 F-NaF and 18 F-FDG PET/CT.
Topics: Adult; Calcinosis; Calculi; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Diseases; Radiopharmaceuticals; Sodium Fluoride | 2022 |
The effects of limb laterality and age on the inflammation and bone turnover of the acromioclavicular shoulder joint: 18 F-fluorodeoxyglucose and 18 F-sodium-fluoride-PET/computed tomography study.
Topics: Adult; Bone Remodeling; Female; Fluorides; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Shoulder; Shoulder Joint; Sodium; Sodium Fluoride | 2022 |
[18F]FDG PET/CT in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sodium Fluoride | 2022 |
A cost effective method for the preparation of sodium fluoride [
Topics: Cost-Benefit Analysis; Diagnostic Imaging; Fluorodeoxyglucose F18; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2023 |
Simultaneous Uptake of 18 F-NaF and 18 F-FDG by Bladder and Prostate Calculi.
Topics: Aged; Calcinosis; Calculi; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostate; Prostatic Diseases; Sodium Fluoride; Urinary Bladder | 2023 |